Ying Chen

FBXW4 Acts as a Protector of FOLFOX-Based Chemotherapy in Metastatic Colorectal Cancer Identified by Co-Expression Network Analysis

Meifang Xu, Xiaojie Wang, Xingrong Lu, 2020, Frontiers in Genetics.

Identification of LncRNAs Associated With FOLFOX Chemoresistance in mCRC and Construction of a Predictive Model

Meifang Xu, Xingrong Lu, P. Chi, 2021, Frontiers in Cell and Developmental Biology.

Overexpressed CES2 has prognostic value in CRC and knockdown CES2 reverses L-OHP-resistance in CRC cells by inhibition of the PI3K signaling pathway.

Meifang Xu, Xiaojie Wang, Xingrong Lu, 2020, Experimental cell research.

Downregulation of Activin A Receptor Type 2A Is Associated with Metastatic Potential and Poor Prognosis of Colon Cancer

Hui Yu, Xiandong Lin, D. Hu, 2018, Journal of Cancer.

Norcantharidin counteracts acquired everolimus resistance in renal cell carcinoma by dual inhibition of mammalian target of rapamycin complex 1 and complex 2 pathways in Vitro

Jinlong Li, Hongwei Li, Xiangsheng Cai, 2021, Anti-cancer drugs.